Geriatric Healthcare Specialist West Linn OR

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment.

Gregory P Garcia, MD
(503) 215-2110
3236 Sabane Lane
West Linn, OR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Univ Of Santo Tomas, Fac Of Med And Surg, Manila, Philippines
Graduation Year: 1992

Data Provided by:
Anthony Arthur Ohotto, MD
(503) 652-6612
13021 SE River Rd
Portland, OR
Specialties
Geriatrics, Geriatric Medicine-Family Practice
Gender
Male
Education
Medical School: Univ Of Mn Med Sch-Minneapolis, Minneapolis Mn 55455
Graduation Year: 1994

Data Provided by:
Kenneth V Brummel Smith, MD
(503) 513-8500
10150 SE 32nd Ave
Portland, OR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Univ Of Southern Ca Sch Of Med, Los Angeles Ca 90033
Graduation Year: 1975

Data Provided by:
Richard M Olson
(503) 571-7503
10180 Se Sunnyside Rd
Clackamas, OR
Specialty
Geriatric Medicine

Data Provided by:
Shirin Ruth Sukumar, MD
(541) 994-9191
618 SW Colony Dr
Portland, OR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Christian Med Coll, Dr M G R Med Univ, Vellore, Tn, India
Graduation Year: 1995
Hospital
Hospital: Samaritan North Lincoln Hosp, Lincoln City, Or
Group Practice: Lincoln City Medical Ctr

Data Provided by:
Shari Ann Sanders
(503) 885-7361
19185 Sw 90th Ave
Tualatin, OR
Specialty
Geriatric Medicine

Data Provided by:
Melinda Ann Lee, MD
(503) 692-4843
6489 SW Borland Rd
Tualatin, OR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Univ Of Ca, San Francisco, Sch Of Med, San Francisco Ca 94143
Graduation Year: 1979

Data Provided by:
David James Vandelindt, MD
(503) 571-3456
9800 SE Sunnyside Rd
Clackamas, OR
Specialties
Geriatrics, Geriatric Psychiatry
Gender
Male
Education
Medical School: Vanderbilt Univ Sch Of Med, Nashville Tn 37232
Graduation Year: 1994

Data Provided by:
M Hester Fieldhouse, MD
Portland, OR
Specialties
Geriatrics, Geriatric Medicine-Family Practice
Gender
Female
Education
Medical School: Or Hlth Sci Univ Sch Of Med, Portland Or 97201
Graduation Year: 1965

Data Provided by:
Peter Richard Rega
(503) 652-2880
9800 Se Sunnyside Rd
Clackamas, OR
Specialty
Geriatric Medicine

Data Provided by:
Data Provided by:

Food for Thought

Provided by: 

By Kris Kucera

Rarely does an extended family get a free pass from Alzheimer’s disease or diabetes mellitus. On the surface, these two afflictions appear totally unrelated —Alzheimer’s (AD), Mother Nature’s cruel version of identity theft; and diabetes, the glucose-metabolism disorder that affects both young and old alike. However, new research indicates that the two diseases behave in a similar manner.

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment. This, they say, suggests that a form of diabetes, tentatively dubbed type 3, leads to AD.

Type 1 diabetes results from a severe or complete lack of insulin, a hormone made in the pancreas that controls blood sugar. Type 2, dubbed adult onset diabetes (although these days it occurs in teenagers and even younger kids), also stems from a dearth of insulin, or insulin resistance —the existing insulin molecules cannot deliver glucose through the cells’ membranes. Surprisingly, the researchers found a new form of insulin, produced in the brain, and they believe that, over time, decreasing levels of this “brain insulin” and other insulin-related proteins ultimately precipitate AD. While levels of brain insulin have no known affect on a body’s overall blood sugar, scientists have long recognized that diabetes patients are more likely to develop AD than those without the disease.

Skeptics of the Brown team’s findings argue that our brains produce so little insulin in the first place, reduced levels of the hormone can’t possibly play a significant role in AD. Regardless, the new data show that AD may be a neuroendocrine disorder, thus increasing the possibility for more effective treatments. And that gives hope to all of us who may one day be touched, directly or indirectly, by the merciless hand of AD.

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...